Metabolomics - Research Accomplishments

In the 2018 – 2022 period the MSR SR supported approximately 240 publications, of which 50 in high-Impact Factor Journals. The MSR’s high Impact Factor publications are shown below:

 

Zhang Z, TeSlaa T, Xu X, Zeng X, Yang L, Xing G, Tesz GJ, Clasquin MF, Rabinowitz JD. Serine catabolism generates liver NADPH and supports hepatic lipogenesis. Nat Metab. 2021;3(12):1608-20. doi: 10.1038/s42255-021-00487-4. PubMed PMID: 34845393; PMCID: PMC8721747.

Genome Editing - Research Accomplishments

In the 2018 – 2022 period, the GESR supported approximately 35 cancer-relevant publications, of which 8 were in high Impact Factor journals:


Tseng HC, Xiong W, Badeti S, Yang Y, Ma M, Liu T, Ramos CA, Dotti G, Fritzky L, Jiang JG, Yi Q, Guarrera J, Zong WX, Liu C, Liu D. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11(1):4810. doi: 10.1038/s41467-020-18444-2. PubMed PMID: 32968061; PMCID: PMC7511348.

Cancer Prevention and Outcomes Data Support - Research Accomplishments

In the 2018 – 2022 period, the Cancer Prevention and Outcomes Data Support Shared Resource supported 19 cancer-relevant publications:

 

Coups EJ, Manne SL, Ohman Strickland P, et al. Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics. Contemp Clin Trials. 2019;83:117-27. doi: 10.1016/j.cct.2019.06.014. PubMed PMID: 31255801; PMCID: PMC6690854.